Rifaximin for the prevention of spontaneous bacterial peritonitis and hepatorenal syndrome in cirrhosis: A systematic review and meta-analysis
European Journal of Gastroenterology & Hepatology | Sep 14, 2017
|Randomized clinical trial: The impact of gastrointestinal risk factor screening and prophylactic proton pump inhibitor therapy in patients receiving dual antiplatelet therapy
European Journal of Gastroenterology & Hepatology | Sep 14, 2017
Most read this week